Small-Intestinal Peutz-Jeghers Polyps Resected by Endoscopic Polypectomy with Double-Balloon Enteroscopy and Removal Confirmed by Ultrasonography

2006 ◽  
Vol 51 (12) ◽  
pp. 2337-2340 ◽  
Author(s):  
Y. Matsumoto ◽  
N. Manabe ◽  
S. Tanaka ◽  
A. Fukumoto ◽  
T. Yamaguchi ◽  
...  
Keyword(s):  
Endoscopic Polypectomy ◽  
Double Balloon Enteroscopy ◽  
Balloon Enteroscopy ◽  
Double Balloon ◽  
Small Intestinal

Usefulness of Double-Balloon Enteroscopy (DBE) for Diagnosis and Treatment of Small Intestinal Diseases

2005 ◽  
Vol 61 (5) ◽  
pp. AB177
Author(s):  
Naoki Ohmiya ◽  
Ayumu Taguchi ◽  
Nobuyuki Mabuchi ◽  
Masayasu Ozeki ◽  
Hironobu Kanazawa ◽  
...  
Keyword(s):  
Diagnosis And Treatment ◽  
Double Balloon Enteroscopy ◽  
Intestinal Diseases ◽  
Balloon Enteroscopy ◽  
Double Balloon ◽  
Small Intestinal

Analysis of the Clinical Features and Endoscopic Treatment of Small Intestinal Angiodysplasia Identified by Using Double-Balloon Enteroscopy

2004 ◽  
Vol 59 (5) ◽  
pp. P156
Author(s):  
Hiroyuki Sato ◽  
Hironori Yamamoto ◽  
Hiroto Kita ◽  
Keijiro Sunada ◽  
Yoshikazu Hayashi ◽  
...  
Keyword(s):  
Clinical Features ◽  
Endoscopic Treatment ◽  
Double Balloon Enteroscopy ◽  
Balloon Enteroscopy ◽  
Double Balloon ◽  
Small Intestinal

scholarly journals Severe Cryptogenic Multifocal Ulcerous Stenosing Enteritis. A Report of Three Cases and Review of the Literature

2010 ◽  
Vol 53 (1) ◽  
pp. 25-29 ◽  
Author(s):  
Darina Kohoutová ◽  
Jan Bureš ◽  
Věra Tyčová ◽  
Jolana Bártová ◽  
Ilja Tachecí ◽  
...  
Keyword(s):  
Weight Loss ◽  
Small Bowel ◽  
Rare Condition ◽  
Review Of The Literature ◽  
Double Balloon Enteroscopy ◽  
Balloon Enteroscopy ◽  
Double Balloon ◽  
Colicky Pain ◽  
Small Intestinal ◽  
Diagnostic Work

Cryptogenic multifocal ulcerous stenosing enteritis (CMUSE) is a rare condition characterised by chronic or relapsing moderate ileous episodes resulting from multiple small intestinal strictures, multiple shallow ulcers of the small bowel and favourable therapeutical effect of glucocorticosteroids. The aim of this paper was to evaluate three cases of CMUSE diagnosed within 10 years at a tertiary gastroenterology centre. Three females (35, 50, 60 years) were presented with colicky pain, repeated moderate ileous episodes and weight loss. Multiple fibrous strictures and ulcers of the small bowel were found. All three patients responded to glucocorticosteroid treatment. Tandem tight jejunal stenoses were dilated endoscopically by means of double balloon enteroscopy. In conclusion, CMUSE should always be considered when chronic moderate ileous episodes and multiple small intestinal strictures and ulcers of uncertain aetiology are found. Double balloon enteroscopy enables precise diagnostic work, possible endoscopic treatment of stenoses, may obviate the need for surgery and prevent excessive small bowel resections.

Clinical Significance of Small Intestinal Involvement Detected by Double-Balloon Enteroscopy In Patients with Non-Hodgkin's Lymphoma

Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 5075-5075
Author(s):  
Hisashi Tsurumi ◽  
Takashi Ibuka ◽  
Takeshi Hara ◽  
Hiroshi Araki ◽  
Soranobu Ninomiya ◽  
...  
Keyword(s):  
Informed Consent ◽  
Clinical Significance ◽  
Hodgkin's Lymphoma ◽  
First Line ◽  
Double Balloon Enteroscopy ◽  
Balloon Enteroscopy ◽  
Double Balloon ◽  
Intestinal Involvement ◽  
Small Intestinal ◽  
Line Chemotherapy

Abstract Abstract 5075 Introduction: Small intestinal lesions without abdominal symptoms are not usually evaluated because of anatomical difficulties with the diagnostic approach to the small intestine. Double-balloon enteroscopy (DBE) can detect gastrointestinal tract lesions of lymphoma, in addition biopsy samples can only be obtained using DBE. Here, we examined the feasibility of DBE to detect small intestinal involvement as well as the clinical significance of such involvement in patients with non-Hodgkin's lymphoma (NHL). Patients and methods: We prospectively screened consecutive patients with first-onset NHL who were admitted to our hospital between March 2004 and August 2009. Among them, adults aged between 18 and 85 years were eligible for inclusion if (1) they had lymphoma infiltration in the stomach, duodenum or colon proven by gastrointestinal endoscopy or colonoscopy, (2) small intestinal involvement was suspected by computed tomography (CT) or Ga scintigraphy (Ga-Scinti)/ 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), or (3) any gastrointestinal symptoms were present. All patients provided written informed consent. Patients underwent DBE using a Fujinon system. Patients with CD20+ B-cell lymphoma received 6–8 cycles of either R-CHOP or R-THP-COP therapy. The R-THP-COP regimen included THP, an anthracycline derivative of DOX with reportedly lower cardiotoxicity than DOX. The patients with CD20-lymphoma received 6–8 cycles of CHOP or THP-COP therapy. Patients with bulky disease underwent radiotherapy ranging from 30 to 40 Gy after chemotherapy. Patients who relapsed or whose disease progressed after first line chemotherapy, and those who were resistant to first line chemotherapy, received the P-IMVP-16/CBDCA (methylprednisolone, ifosfamide, methotrexate, etoposide and carboplatin) regimen with or without R as a second line therapy. Some patients with refractory or relapsed NHL who responded to (R)-P-IMVP-16/CBDCA received high-dose chemotherapy followed by autologous stem cell transplantation. Results: Among 318 patients with histologically confirmed NHL between 2004 and 2009. 58 patients were eligible for DBE. Unfortunately, we could not achieve the informed consent in 16 patients and clinical conditions were too severe to undergo DBE in 4 patients. After all, we could undergo DBE in 38 patients. Their median age of the 38 patients was 65 years (range, 38–82). We confirmed small intestinal involvement in 21 (55%) of 38 patients by DBE. Complete remission (CR) or CR uncertain (CRu) rates of patients with small intestinal involvement of lymphoma (n=21, 48%) was significantly lower than that in other patients (n=297, 71%) or that in patients without small intestinal involvement confirmed by DBE (n=17, 88%). The 3-y OS rate of the patients with small intestinal involvement of lymphoma (n=21, 41%) was significantly lower than that in other patients (n=297, 77%) (P<0.0001) and that in patients without small intestinal involvement confirmed by DBE (n=17, 88%). The impact of small intestinal involvement on survival was compared using multivariate analysis with those of current clinicopathological prognostic factors. Small intestinal involvement of lymphoma was the significant prognostic factor in all lymphoma patients (3.25; 1.50–6.40; p = 0.0039) and in the patients who underwent DBE (4.59; 1.03–32.5; p = 0.0444). Aspiration pneumonia developed in 3 of 38 patients after DBE, but they improved with antibiotic therapy. No deaths were associated with DBE. Conclusion: The small intestinal involvement might indicate a poor prognosis. DBE can directly and precisely evaluate the lesions and thus help to determine the most appropriate treatment strategy for such patients. Disclosures: No relevant conflicts of interest to declare.

Sign in / Sign up

Export Citation Format

Share Document